John Didsbury

4.5k citations

28 papers · 2.4k indexed · h-index 19

Immunology and Allergy top 2%
- Cell Adhesion Molecules Research 3
Immunology top 5%
- Toxin Mechanisms and Immunotoxins 3
Physiology top 2%
- Erythrocyte Function and Pathophysiology 3
- Alzheimer's disease research and treatments 2
Cell Biology top 5%
- Cellular transport and secretion 3
Molecular Biology top 5%
- Receptor Mechanisms and Signaling 6
- Protein Kinase Regulation and GTPase Signaling 5
Cellular and Molecular Neuroscience
- Neuropeptides and Animal Physiology 5

Co-authors: Ralph Snyderman R F Weber Timothy A. Evans Gary Bokoch Eric D. Tomhave Luc Ménard Ricardo M. Richardson Д. В. Коваленко
Cited by: Immunology and Allergy Immunology Physiology
Journals: Journal of Biological Chemistry (6 papers)Alzheimer s & Dementia (4 papers)Biochemical and Biophysical Research Communications (3 papers)
Partner nations: United States Netherlands Germany

In The Last Decade

John Didsbury

26 papers receiving 2.3k citations

Peers

Countries citing papers authored by John Didsbury

Since Specialization

Citations

This map shows the geographic impact of John Didsbury's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Didsbury with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Didsbury more than expected).

Fields of papers citing papers by John Didsbury

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Didsbury. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Didsbury. The network helps show where John Didsbury may publish in the future.

Co-authorship network

The 25 scholars most cited alongside John Didsbury, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John Didsbury Line = papers co-authored together John Didsbury links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Phase 2 PIONEER Trial of Oral T3D‐959 for the Treatment of Patients Diagnosed with Mild‐to‐Moderate Alzheimer’s Disease: New Results in a Modified Intent‐to‐Treat Population Alzheimer s & Dementia ·Ekaterina V. Ivanovskaya,Shiming Yang,Warren J. Strittmatter,غلام رضا محمدپور,Wang Ting-fu,杨卓姝,Charles G. Lineberry,John Didsbury	2024	1
2	The PIONEER Study: A multi‐center, randomized, double‐blind, placebo‐controlled phase 2 trial of the effects of T3D‐959 on safety, cognition, function and plasma biomarkers in mild to moderate Alzheimer’s disease subjects: Rationale and study design Alzheimer s & Dementia ·John Didsbury,Warren J. Strittmatter,غلام رضا محمدپور,Wang Ting-fu	2020	3
3	An Exploratory Phase IIa Study of the PPAR delta/gamma Agonist T3D-959 Assessing Metabolic and Cognitive Function in Subjects with Mild to Moderate Alzheimer’s Disease Journal of Alzheimer s Disease ·Stanley D. Chamberlain,Wang Ting-fu,Warren J. Strittmatter,John Didsbury	2019	39
4	Improved Brain Insulin/IGF Signaling and Reduced Neuroinflammation with T3D-959 in an Experimental Model of Sporadic Alzheimer’s Disease Journal of Alzheimer s Disease ·Suzanne M. de la Monte,Ming Tong,Carlos Melo Labra,John Didsbury	2016	59
5	P4‐390: Rapid Onset of Cognitive Improvements in a Subset of Mild and Moderate Alzheimer’S Patients Treated with T3D‐959: Interim Results of a Phase 2A Open Label Clinical Trial Alzheimer s & Dementia ·John Didsbury	2016	0
6	P4‐318: T3D‐959: A multi‐faceted disease remedial drug candidate for the treatment of Alzheimer's disease Alzheimer s & Dementia ·John Didsbury,Suzanne de la Monte	2015	3
7	NF-κB activation provides the potential link between inflammation and hyperplasia in the arthritic joint Proceedings of the National Academy of Sciences ·Alexei Miagkov,Д. В. Коваленко,Birrell James,John Didsbury,John Cogswell,Stephen A. Stimpson,Albert S. Baldwin,Sergei S. Makarov	1998	397
8	STRUCTURAL FEATURES AND BIOCHEMICAL PROPERTIES OF TNF-ALPHA CONVERTASE Shock ·Marcia L. Moss,Chunyang Jin,Mani Kumar Sharma,Andrey Letsko,William Burkhart,SIXTO GONZÁLEZ-VÍLLORA,Aysha Almeree,John Didsbury,Daniel F. Hassler,Thomas A. Kost,Paola Fajardo‐Heyward,Gerard M. McGeehan,Abolfazl Soleimani,Mary B. Moyer,Marcos E. Milla,Zhang Mao-liang,Warren J. Rocque,Theresa Seaton,Janet Warner,Derril H. Willard	1997	0
9	Cross-desensitization of receptors for peptide chemoattractants. Characterization of a new form of leukocyte regulation. The Journal of Immunology ·Eric D. Tomhave,Ricardo M. Richardson,John Didsbury,Luc Ménard,Ralph Snyderman,Hakim Azfar Ali	1994	147
10	Differences in phosphorylation of formylpeptide and C5a chemoattractant receptors correlate with differences in desensitization. Journal of Biological Chemistry ·Hydar Ali,Ricardo M. Richardson,Eric D. Tomhave,John Didsbury,Ralph Snyderman	1993	148
11	Rac1, a low‐molecular‐mass GTP‐binding‐protein with high intrinsic GTPase activity and distinct biochemical properties European Journal of Biochemistry ·Luc Ménard,Eric D. Tomhave,Patrick J. Casey,Ronald J. Uhing,Ralph Snyderman,John Didsbury	1992	46
12	Both stimulatory and inhibitory exchange proteins, smg GDS and rho GDI, are active on multiple small GTP-binding proteins Biochemical and Biophysical Research Communications ·Kunihiko Hiraoka,Kozo Kaibuchi,Satoshi Ando,A Castano-Calvo,Kenji Takaishi,Takakazu Mizuno,Makoto Asada,Luc Ménard,Eric D. Tomhave,John Didsbury,Ralph Snyderman,Yoshimi Takai	1992	104
13	Differential regulation of cAMP by endogenous versus transfected fornylpeptide chemoattractant receptors: Implications for Gi-coupled receptor signaling Biochemical and Biophysical Research Communications ·Ronald J. Uhing,Thomas W. Gettys,Eric D. Tomhave,Ralph Snyderman,John Didsbury	1992	12
14	Isoprenylation of the low molecular mass GTP-binding proteins rac 1 and rac 2: Possible role in membrane localization Biochemical and Biophysical Research Communications ·John Didsbury,Ronald J. Uhing,Ralph Snyderman	1990	44
15	Modification of the rat adipocyte A1 adenosine receptor-adenylate cyclase system during chronic exposure to an A1 adenosine receptor agonist: alterations in the quantity of GS alpha and Gi alpha are not associated with changes in their mRNAs. Molecular Pharmacology ·J.Peter Longabaugh,John Didsbury,Allen M. Spiegel,Gary L. Stiles	1989	109
16	rac, a novel ras-related family of proteins that are botulinum toxin substrates Journal of Biological Chemistry ·John Didsbury,R F Weber,Gary Bokoch,Timothy A. Evans,Ralph Snyderman	1989	478
17	Molecular cloning of a novel human GTP-binding protein and its potential role in chemoattractant stimulus-response coupling. PubMed ·John Didsbury,Ralph Snyderman	1987	5
18	Molecular cloning of a new human G protein Evidence for two G_iα‐like protein families FEBS Letters ·John Didsbury,Ralph Snyderman	1987	52
19	Multiple red cell ferritin mRNAs, which code for an abundant protein in the embryonic cell type, analyzed by cDNA sequence and by primer extension of the 5'-untranslated regions. Journal of Biological Chemistry ·John Didsbury,E C Theil,Russel E. Kaufman,L F Dickey	1986	63
20	Binding and Uptake of Diphtheria Toxin by Toxin-Resistant Chinese Hamster Ovary and Mouse Cells Molecular and Cellular Biology ·John Didsbury,Joan M. Moehring,Thomas J. Moehring	1983	11

About John Didsbury

John Didsbury is a scholar working on Biological Psychiatry, Immunology and Allergy, Cellular and Molecular Neuroscience, Molecular Biology and Physiology, having authored 28 papers that have together received 2.4k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (6 papers), Protein Kinase Regulation and GTPase Signaling (5 papers), Neuropeptides and Animal Physiology (5 papers), Erythrocyte Function and Pathophysiology (3 papers), Cellular transport and secretion (3 papers), Cell Adhesion Molecules Research (3 papers), Toxin Mechanisms and Immunotoxins (3 papers) and Alzheimer's disease research and treatments (2 papers). The work is most often cited by research in Immunology and Allergy (229 citations), Immunology (737 citations), Physiology (132 citations), Cell Biology (373 citations) and Molecular Biology (1.4k citations). John Didsbury has collaborated with scholars based in United States, Netherlands and Germany. Frequent co-authors include Ralph Snyderman, R F Weber, Timothy A. Evans, Gary Bokoch, Eric D. Tomhave, Luc Ménard, Ricardo M. Richardson, Д. В. Коваленко, Sergei S. Makarov and Alexei Miagkov. Their work appears in journals such as Journal of Biological Chemistry, Alzheimer s & Dementia, Biochemical and Biophysical Research Communications, Journal of Alzheimer s Disease and FEBS Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact